Prognostic significance of p16 and its relationship with human papillomavirus in pharyngeal squamous cell carcinomas

JAMA Otolaryngology - Head and Neck Surgery

Volumn 140, Issue 7, 2014, Pages 647-653

  Wilson, David D ^a   Crandley, Edwin F ^a   Sim, Austin ^a   Stelow, Edward B ^b   Majithia, Neil ^a   Shonka Jr , David C ^b   Jameson, Mark J ^b   Levine, Paul A ^b   Read, Paul W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHARYNX CARCINOMA; PREDICTIVE VALUE; PREVALENCE; PRIMARY TUMOR; RETROSPECTIVE STUDY; SCREENING TEST; SQUAMOUS CELL CARCINOMA; TERTIARY CARE CENTER; WART VIRUS;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNX; OROPHARYNX; PARAINFLUENZA VIRUS 1, HUMAN; PHARYNGEAL NEOPLASMS; PHARYNX; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REGRESSION ANALYSIS;

EID: 84905046208     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2014.821     Document Type: Article

References (25)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1): 24-35.
2. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120(8):1731-1738. (Pubitemid 46399359)
3. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer. 2010;116(11):2645-2654.
4. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24(5): 736-747. (Pubitemid 46622040)
5. Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2014;36(4): 511-516.
6. Wilson DD, Rahimi AS, Saylor DK, et al. p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2012;138(6):556-561.
7. Wendt M, Romanitan M, Nasman A, et al. Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer. Head Neck. 2014;36(1):107-112.
8. Sheng K, Chow MC, Hunter G, Larner JM, Read PW. Is daily CT image guidance necessary for nasal cavity and nasopharyngeal radiotherapy: an investigation based on helical tomotherapy. J Appl Clin Med Phys. 2008;9(1):2686.
9. Lewis JS Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34(8): 1088-1096.
10. Rahimi AS, Wilson DD, Saylor DK, et al. p16, cyclin D1, and HIF-1α predict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensity-modulated radiation therapy. Int J Otolaryngol. 2012;2012: 685951.
11. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813-1820. (Pubitemid 47417302)
12. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24(17):2606-2611. (Pubitemid 46622080)
13. Rodrigo JP, González MV, Lazo PS, et al. Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features. Oral Oncol. 2002;38 (4):357-363. (Pubitemid 34655690)
14. Deng Z, Hasegawa M, Matayoshi S, et al. Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. Eur Arch Otorhinolaryngol. 2011;268(11):1625-1631.
15. Singhi AD, Califano J, Westra WH. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck. 2012;34(2):213-218.
16. Punwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirusmay be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck. 1999;21(1):21-29. (Pubitemid 29006452)
17. Rassekh CH, Rady PL, Arany I, et al. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope. 1998;108(3):362-367. (Pubitemid 28136643)
18. Park JM, Jung CK, Choi YJ, et al. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma. Hum Pathol. 2010;41(3):431-437.
19. Karsai S, Abel U, Roesch-Ely M, et al. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol. 2007;211(3):314-322. (Pubitemid 46172707)
20. Maxwell JH, Kumar B, Feng FY, et al. HPV-positive/p16-positive/EBV- negative nasopharyngeal carcinoma in white North Americans. Head Neck. 2010;32(5):562-567.
21. Chen SW, Yang SN, Liang JA, Lin FJ, Tsai MH. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck. 2009;31(6):709-716.
22. Hall SF, Groome PA, Irish J, O'Sullivan B. Towards further understanding of prognostic factors for head and neck cancer patients: the example of hypopharyngeal cancer. Laryngoscope. 2009;119(4):696-702.
23. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64(1):57-62. (Pubitemid 41831209)
24. O'Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013;31(5):543-550.
25. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121(11):2465-2472. (Pubitemid 350022416)